Evidence map›Paper›PMID 32589791›Full record

ArticleBiotechnology and bioengineering2020

Human trabecular meshwork cell behavior is influenced by collagen scaffold pore architecture and glycosaminoglycan composition.

Matthew J Osmond, Melissa D Krebs, Mina B Pantcheva

Open access · greenAbstract read
In one paragraph

Article in Biotechnology and bioengineering, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. iPSCs-Based Therapy for Trabecular Meshwork.Handbook of experimental pharmacology · 2023
    Article
  13. Review
  14. Article
  15. Schlemm's canal: the outflow 'vessel'.Acta ophthalmologica · 2022
    Review
  16. An Optimized Method to Decellularize Human Trabecular Meshwork.Bioengineering (Basel, Switzerland) · 2022
    Article
  17. Article
  18. Review
  19. Glaucoma in mucopolysaccharidoses.Orphanet journal of rare diseases · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Matthew J OsmondDepartment of Chemical & Biological Engineering, Colorado School of Mines, Golden, Colorado.ORCID 0000-0002-4778-9067
Melissa D KrebsDepartment of Chemical & Biological Engineering, Colorado School of Mines, Golden, Colorado.ORCID 0000-0002-5170-7116
Mina B PantchevaDepartment of Ophthalmology, University of Colorado School of Medicine, Aurora, Colorado.ORCID 0000-0002-7452-4523
Colorado School of Mines · USUniversity of Colorado Denver · US

Funding

Development of a 3D Human Trabecular Meshwork Cell Culture System Using Natural Biopolymer ScaffoldsR15EY027111 · NEI · COLORADO SCHOOL OF MINES · PI KREBS, MELISSA · 2017 to 2017
$420k
NEI NIH HHS 1R15EY027111NEI NIH HHS R15 EY027111
6 · The paper itself

Abstract

Glaucoma is a degenerative eye disease in which damage to the optic nerve leads to a characteristic loss of vision. The primary risk factor for glaucoma is an increased intraocular pressure that is caused by an imbalance of aqueous humor generation and subsequent drainage through the trabecular meshwork (TM) drainage system. The small size, donor tissue limitations, and high complexity of the TM make it difficult to research the relationship between the TM cells and their immediate environment. Thus, a biomaterial-based approach may be more appropriate for research manipulations and in vitro drug development platforms. In this work, human TM (hTM) cells were cultured on various collagen scaffolds containing different glycosaminoglycans (GAGs) and different pore architectures to better understand how hTM cells respond to changes in their extracellular environment. Cellular response was measured by quantifying cellular proliferation and expression of an important extracellular matrix protein, fibronectin. The pore architecture of the scaffolds was altered using freeze-casting technique to make both large and small pores that were aligned or with a non-aligned random structure. The composition of the scaffolds was altered with the addition of chondroitin sulfate and/or hyaluronic acid. It was found that the hTM cells grown on large pore scaffolds proliferate more than those grown on small pores. There was an increase in the fibronectin expression with the incorporation of GAGs, and its morphology was changed by the underlying pore architecture. This work will help provide an insight into the behavior of hTM cells when introducing changes in their microenvironment.

Indexed as

Biocompatible MaterialsChondroitin SulfatesCollagenFibronectinsGlycosaminoglycansHumansTissue ScaffoldsTrabecular MeshworkBiocompatible MaterialsChondroitin SulfatesCollagenFibronectinsGlycosaminoglycanscollagenglaucomaglycosaminoglycantrabecular meshwork

Identifiers

PMID32589791
PMCPMC8360228
OpenAlexW3037531265

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.